Tolvaptan in Patients with Autosomal Dominant Polycystic Kidney Disease

BACKGROUND: The course of autosomal dominant polycystic kidney disease (ADPKD) is often associated with pain, hypertension, and kidney failure. Preclinical studies indicated that vasopressin V(2)-receptor antagonists inhibit cyst growth and slow the decline of kidney function. METHODS: In this phase...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Asıl Yazarlar: Torres, Vicente E., Chapman, Arlene B., Devuyst, Olivier, Gansevoort, Ron T., Grantham, Jared J., Higashihara, Eiji, Perrone, Ronald D., Krasa, Holly B., Ouyang, John, Czerwiec, Frank S.
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: 2012
Konular:
Article
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC3760207/
https://ncbi.nlm.nih.gov/pubmed/23121377
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1056/NEJMoa1205511
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller